A

Annovis Bio
D

ANVS

2.13000
USD
-0.09
(-4.05%)
مغلق
حجم التداول
22,306
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
41,505,672
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    APLS
    -0.850
    (-3.00%)
    27.510 USD
    C
    CRBP
    -0.09000
    (-1.09%)
    8.20000 USD
    C
    CTMX
    -0.03570
    (-4.38%)
    0.78000 USD
    D
    DARE
    0.01000
    (0.32%)
    3.18000 USD
    F
    FATE
    -0.13500
    (-8.74%)
    1.41000 USD
    M
    MEIP
    -0.05000
    (-1.89%)
    2.60000 USD
    المزيد
الأخبار
المقالات

العنوان: Annovis Bio

القطاع: Healthcare
الصناعة: Biotechnology
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the companyconsists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.